PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine, University of Southampton, Southampton, UK.\', \'NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK.\', \'Translational Science and Experimental Medicine, Research and Early Development, AstraZeneca, Respiratory & Immunology, BioPharmaceuticals R&D, Gothenburg, Sweden.\', \'Translational Genomics, Discovery Biology, Discovery Sciences, AstraZeneca, BioPharmaceuticals R&D, Gothenburg, Sweden.\', \'Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.\', \'Clinical Development, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.\', \'Faculty of Medicine, University of Southampton, Southampton, UK. t.wilkinson@soton.ac.uk.\', \'NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK. t.wilkinson@soton.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12931-021-01755-3
?:doi
?:hasPublicationType
?:journal
  • Respiratory research
is ?:pmid of
?:pmid
?:pmid
  • 34051791
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.644
?:rankingScore_hIndex
  • 89
is ?:relation_isRelatedTo_publication of
?:title
  • Dysregulation of COVID-19 related gene expression in the COPD lung.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all